Jensen Ashley W, Brown Paul D, Pollock Bruce E, Stafford Scott L, Link Michael J, Garces Yolanda I, Foote Robert L, Gorman Deborah A, Schomberg Paula J
Department of Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USA.
Int J Radiat Oncol Biol Phys. 2005 May 1;62(1):32-7. doi: 10.1016/j.ijrobp.2004.09.033.
To determine local control (LC) and complication rates for patients who underwent radiosurgery for radiation-induced intracranial tumors.
Review of a prospectively maintained database (2,714 patients) identified 16 patients (20 tumors) with radiation-induced tumors treated with radiosurgery between 1990 and 2004. Tumor types included typical meningioma (n=17), atypical meningioma (n=2), and schwannoma (n=1). Median patient age at radiosurgery was 47.5 years (range, 27-70 years). The median tumor margin dose was 16 Gy (range, 12-20 Gy). Median follow-up was 40.2 months (range, 10.8-146.2 months). Time-to-event outcomes were calculated with Kaplan-Meier estimates.
Three-year and 5-year LC rates were 100%. Three-year and 5-year overall survival rates were 92% and 80%, respectively. Cause-specific survival rates at 3 and 5 years were 100%. Three patients died: 1 had in-field progression 65.1 months after radiosurgery and later died of the tumor, 1 died of progression of a preexisting brain malignancy, and 1 died of an unrelated cause. One patient had increased seizure activity that correlated with development of edema seen on neuroimaging.
LC, survival, and complication rates in our series are comparable to those in previous reports of radiosurgery for intracranial meningiomas. Also, LC rates with radiosurgery are at least comparable to those of surgical series for radiation-induced meningiomas. Radiosurgery is a safe and effective treatment option for radiation-induced intracranial tumors, most of which are typical meningiomas.
确定接受放射外科治疗放射性颅内肿瘤患者的局部控制率(LC)和并发症发生率。
回顾一个前瞻性维护的数据库(2714例患者),确定了1990年至2004年间接受放射外科治疗的16例(20个肿瘤)放射性肿瘤患者。肿瘤类型包括典型脑膜瘤(n = 17)、非典型脑膜瘤(n = 2)和神经鞘瘤(n = 1)。放射外科治疗时患者的中位年龄为47.5岁(范围27 - 70岁)。肿瘤边缘剂量中位数为16 Gy(范围12 - 20 Gy)。中位随访时间为40.2个月(范围10.8 - 146.2个月)。采用Kaplan-Meier估计计算事件发生时间结局。
3年和5年局部控制率均为100%。3年和5年总生存率分别为92%和80%。3年和5年病因特异性生存率均为100%。3例患者死亡:1例在放射外科治疗后65.1个月出现野内进展,随后死于肿瘤;1例死于原有脑恶性肿瘤进展;1例死于无关原因。1例患者癫痫活动增加,与神经影像学上显示的水肿发展相关。
我们系列研究中的局部控制率、生存率和并发症发生率与先前颅内脑膜瘤放射外科治疗的报告结果相当。此外,放射外科治疗的局部控制率至少与放射性脑膜瘤手术系列的结果相当。放射外科是放射性颅内肿瘤的一种安全有效的治疗选择,其中大多数为典型脑膜瘤。